Increase/Decrease in Cash: The total change in cash for the company over the given period.
Evogene Ltd. (EVGN) had Increase/Decrease in Cash of $-3.64M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.35M |
|
$-1.77M |
|
$0.21M |
|
$0.14M |
|
$2.91M |
|
$-2.56M |
|
$0.97M |
|
$-1.59M |
|
$-1.59M |
|
$-1.59M |
|
$-1.59M |
|
$-1.77M |
|
$-1.59M |
|
$-2.56M |
|
$-2.43M |
|
12.20M |
|
12.20M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$10.85M |
|
$0.50M |
|
$2.59M |
|
$13.44M |
|
$3.04M |
|
-- |
|
$4.63M |
|
$7.67M |
|
$5.77M |
|
$5.77M |
|
$5.77M |
|
13.54M |
|
| Cash Flow Statement Financials | |
$-4.93M |
|
$0.13M |
|
$1.16M |
|
$12.96M |
|
$9.32M |
|
|
Increase/Decrease in Cash |
$-3.64M |
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
40.63% |
|
-738.62% |
|
-738.62% |
|
-- |
|
-458.50% |
|
-509.51% |
|
$-4.83M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
2.22 |
|
0.25 |
|
365.71 |
|
-27.58% |
|
-27.58% |
|
-11.84% |
|
-27.58% |
|
$0.43 |
|
$-0.40 |
|
$-0.40 |
|